CUROXIA MR

Introduction

CUROXIA MR is a prescription medicine containing Etoricoxib 60 mg and Thiocolchicoside 4 mg, a combination designed for the symptomatic management of painful musculoskeletal conditions associated with inflammation and muscle spasm.

Etoricoxib is a selective cyclooxygenase-2 (COX-2) inhibitor that provides effective relief from pain and inflammation, while Thiocolchicoside is a centrally acting muscle relaxant that helps relieve painful muscle spasm and improves muscle mobility. Together, they provide complementary relief from pain, inflammation, muscle stiffness, and restricted movement associated with acute musculoskeletal disorders. Etoricoxib is an established therapy for osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, acute gout, and short-term dental pain, while thiocolchicoside is used for painful muscle contractures.

When prescribed by a healthcare professional, CUROXIA MR helps improve patient comfort, mobility, and functional recovery in acute painful musculoskeletal conditions.

Uses of CUROXIA MR

CUROXIA MR is indicated for the symptomatic relief of pain, inflammation, and muscle spasm.

It may be prescribed for:

1. Acute low back pain with muscle spasm
2. Cervical pain (neck pain) with muscle spasm
3. Acute musculoskeletal disorders
4. Osteoarthritis associated with painful muscle spasm
5. Painful muscle contractures
6. Other acute painful musculoskeletal conditions, as advised by a healthcare professional

Note: CUROXIA MR provides symptomatic relief and does not treat the underlying cause of the condition. Thiocolchicoside should be used only for short-term treatment because of established safety recommendations.

Benefits of CUROXIA MR

CUROXIA MR combines a selective COX-2 inhibitor with a centrally acting muscle relaxant to provide comprehensive management of painful musculoskeletal conditions.

Scientific benefits include:

1. Provides effective relief from pain, inflammation, and muscle spasm.
2. Helps improve mobility by reducing painful muscle stiffness.
3. Relieves pain associated with acute low back pain and cervical muscle spasm.
4. Selective COX-2 inhibition provides anti-inflammatory and analgesic effects with a lower incidence of upper gastrointestinal ulceration than non-selective NSAIDs, although cardiovascular risk assessment remains important.
5. Fixed-dose combination offers convenient administration and may improve treatment adherence.
6. Best suited for short-term management of acute musculoskeletal pain accompanied by muscle spasm.

How CUROXIA MR Works

CUROXIA MR works through the complementary actions of its two active ingredients.

Etoricoxib selectively inhibits the cyclooxygenase-2 (COX-2) enzyme, reducing the production of prostaglandins that mediate pain and inflammation. This helps relieve pain, decrease inflammation, and improve joint function.

Thiocolchicoside is a centrally acting muscle relaxant that acts on inhibitory pathways within the central nervous system to reduce painful muscle spasm without directly affecting skeletal muscle strength. This helps relieve muscle stiffness and improves movement.

Together, these complementary mechanisms help relieve pain, reduce inflammation, relax muscle spasm, and improve functional mobility.

Dosage & Administration

CUROXIA MR should be used only under the supervision of a qualified healthcare professional.

General Adult Dosage

1. Take the tablet exactly as prescribed by your physician.
2. It may be taken with or without food, although taking it after food may help reduce stomach discomfort.
3. Swallow the tablet whole with a glass of water.
4. Thiocolchicoside-containing medicines are generally recommended for short-term use, unless otherwise directed by the treating physician.

Possible Side Effects

Like all medicines, CUROXIA MR may cause side effects, although not everyone experiences them.

Commonly reported side effects include:

1. Headache
2. Dizziness
3. Nausea
4. Abdominal discomfort
5. Indigestion
6. Diarrhea
7. Drowsiness
8. Dry mouth

Patients should seek immediate medical attention if they develop chest pain, difficulty breathing, severe allergic reactions, black stools, persistent vomiting, seizures, or severe skin reactions.

Contraindications & Precautions

CUROXIA MR should not be used in patients with:

1. Known hypersensitivity to Etoricoxib, Thiocolchicoside, NSAIDs, or any component of the formulation.
2. Active peptic ulcer disease or gastrointestinal bleeding.
3. Severe hepatic impairment.
4. Severe renal impairment.
5. Severe heart failure.
6. Established ischemic heart disease, peripheral arterial disease, or cerebrovascular disease where Etoricoxib is contraindicated.
7. Pregnancy or breastfeeding.
8. Women of childbearing potential not using effective contraception (due to Thiocolchicoside safety concerns).

Important Precautions

CUROXIA MR should be used with caution in patients with:

1. Hypertension or cardiovascular risk factors.
2. Mild to moderate hepatic or renal impairment.
3. Elderly patients.
4. History of gastrointestinal disorders.
5. Patients receiving anticoagulants or other NSAIDs.
6. Patients requiring prolonged pain management.

Blood pressure should be monitored during treatment with Etoricoxib, and the medicine should be used for the shortest appropriate duration.

Disclaimer

The information provided on this page is intended for educational purposes only and should not replace professional medical advice, diagnosis, or treatment. CUROXIA MR is a prescription medicine and should be used only under the supervision of a qualified healthcare professional. Patients should always follow their physician's advice regarding dosage, duration of treatment, and monitoring. Clinical decisions should be individualized based on the patient's medical condition, medical history, and current evidence-based clinical guidelines.